SCHEMBL7695822

SCHEMBL7695822

CC(C)CCNc1nc2cc3ccccc3cc2nc1NCCC(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
MAPK1 P28482 1/20 0.44
UTS2R Q9UKP6 1/20 0.43
NQO2 P16083 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
POLB P06746 1/20 0.39
IKBKB O14920 4/20 0.39
CHUK O15111 4/20 0.39
ELANE P08246 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL28842236 0.80 KDM4E (0.47) KDM4EMAPK1UTS2RPOLBELANE
SCHEMBL7695991 0.78 MAPT (0.48) KDM4EMAPK1POLBALDH1A1MAPT
SCHEMBL7695556 0.77 KDM4E (0.75) KDM4EMAPK1NQO2CYP2C19POLB
SCHEMBL7691825 0.76 JAK2 (0.46) MAPK1MAPTLMNAHPGDHTT
SCHEMBL7691871 0.74 KDM4E (0.59) KDM4EMAPK1NQO2POLBIKBKB
SCHEMBL4353261 0.72 MAP4K4 (0.54) KDM4EMAPK1CYP1A2CYP2C9CYP2C19
SCHEMBL7699335 0.70 ACP1 (0.55) KDM4ECYP1A2CYP2C9CYP2C19MAPT
SCHEMBL4860036 0.69 ACP1 (0.74) KDM4EMAPK1POLBALDH1A1MAPT
SCHEMBL28798228 0.69 PCSK9 (0.56) KDM4EUTS2RCYP1A2CYP2C8CYP2C9
SCHEMBL1548538 0.67 ALDH1A1 (0.56) MAPK1CYP1A2CYP2C8CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed